4SC AG Logo

4SC AG

Biopharmaceutical company with no products under development or operational business.

VSC | F

Overview

Corporate Details

ISIN(s):
DE000A3E5C40
LEI:
391200QOKN7LGVP0RQ86
Country:
Germany
Address:
Fraunhoferstr. 22, 82152 Planegg

Description

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2014-05-10 00:00
Q1 Report 2014
English PDF 3.3 MB
2014-05-08 07:31
Press Release: 4SC Announces Financial Results for the First Quarter of 2014
English HTML 21.9 KB
2014-05-06 07:30
Press Release: 4SC's partner Yakult Honsha completes Phase I study with resmino…
English HTML 13.6 KB
2014-05-02 13:00
Announcement: 4SC to host conference call on 8 May 2014 to present first quarte…
English HTML 7.5 KB
2014-04-30 18:59
4 SC AG: Release according to Article 26a of the WpHG [the German Securities Tr…
English HTML 1.5 KB
2014-04-15 14:26 English HTML 1.7 KB
2014-04-15 07:30
Press Release: 4SC Discovery receives EU grant worth EUR 450,000 for the resear…
English HTML 12.8 KB
2014-04-07 00:00
Annual Financial Statements 2013
English PDF 2.6 MB
2014-04-07 00:00
Jahresfinanzbericht 2013
German PDF 3.4 MB
2014-03-31 15:10
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.05.2014 in M…
German HTML 90.6 KB
2014-03-31 12:30
4 SC AG: Veroffentlichung der Gesamtzahl der Stimmrechte nach 26a WpHG mit dem…
German HTML 1.6 KB
2014-03-26 07:30
Press Release: 4SC publishes results for financial year 2013 and announces chan…
English HTML 26.1 KB
2014-03-20 07:30
Press Release: 4SC Discovery collaborates with Heidelberg University Hospital a…
English HTML 12.4 KB
2014-03-19 15:00
Announcement: 4SC to host conference call on 26 March 2014 to present annual re…
English HTML 7.4 KB
2014-03-04 16:15
4SC AG issues first tranche of convertible notes with a nominal amount of EUR 5…
English HTML 5.2 KB

Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 4SC AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 4SC AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900
ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.